Reaction

Portal Hypertensive Gastropathy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 549 reports · 21 co-occurring drugs

As of the last recalculation, Portal Hypertensive Gastropathy appears in 549 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is NEVIRAPINE (PRR 100.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Nevirapine23100.8101.1
Zidovudine2574.274.4
Efavirenz2070.570.7
Rifaximin3567.667.7
Tenofovir Disoproxil Fumarate Tablets1463.163.2
Lamivudine Oral3657.757.7
Lamivudine3647.247.3
Ritonavir 100 Mg1847.247.3
Ursosiol2346.846.8
Lactulose4346.146.1
Thiamine Hydrochloride1443.743.8
Ursodiol2443.643.7
Sofosbuvir1529.629.6
Ritonavir2026.926.9
Epoprostenol926.526.5
Sorafenib1324.324.3
Atezolizumab2121.321.3
Oxaliplatin3619.619.6
Tenofovir Disoproxil Fumarate1618.918.9
Iohexol313.813.8
Ledipasvir And Sofosbuvir59.99.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.